ETFs positioned on Vertex Pharmaceuticals Incorporated

Name YTD change Weight AuM
+14.03%-.--% 44,934 M€
+19.44%-.--% 35,761 M€
+8.49%-.--% 28 M€
+2.55%-.--% 33 M€
+15.62%-.--% 33 M€
+6.61%-.--% 37 M€
+4.25%-.--% 49 M€
+10.13%-.--% 66 M€
+11.24%-.--% 67 M€
+8.05%-.--% 75 M€
+7.25%-.--% 80 M€
+14.19%-.--% 122 M€
+2.42%-.--% 293 M€
+12.29%-.--% 27,154 M€
+17.65%-.--% 750 M€
+11.08%-.--% 507 M€
+5.12%-.--% 165 M€
+19.36%-.--% 148 M€
+28.85%9.51% 15 M€
+27.05%9.43% 429 M€
+21.24%9.05% 78 M€
+21.64%9.05% 1,079 M€
+22.35%8.88% 9,953 M€
+21.92%8.54% 81 M€
+22.68%4.47% 7 M€
+8.49%4.4% 28 M€
+30.26%4.33% 11 M€
+55.10%4.15% 58 M€
+44.82%4.13% 87 M€
Logo Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases. Net sales are distributed geographically as follows: the United States (62.9%), Europe (28.8%) and other (8.3%).
Employees
6,400
  1. Stock Market
  2. Stocks
  3. VRTX Stock
  4. ETFs Vertex Pharmaceuticals Incorporated